SynthesisAmerican journal of clinical dermatology2022
Skin Cancer in People of Color: A Systematic Review.
Synthesis in American journal of clinical dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Knowledge and Risk Perception Regarding Skin Cancer in Immunosuppressed Patients: A Systematic Review and Meta-Analysis.European journal of investigation in health, psychology and education · 2026Review
- International Expert Consensus on Knowledge Gaps in Care for Dermatologic Disorders in Skin of Color.International journal of dermatology · 2026Article
- Exploring Skin Tone Diversity in a Plastic Surgery Resident Education Curriculum.Plastic surgery (Oakville, Ont.) · 2025Article
- Epidemiological and Pathological Trends in Skin Cancer: A Hands-On Analysis of 10 Years of Data from the Saudi Cancer Registry.Cancer management and research · 2025Article
- Syndemic geographic patterns of cancer risk in a health-deprived area of England.Public health in practice (Oxford, England) · 2024Article
- Racial and ethnic differences in healthcare access and utilization among U.S. adults with melanoma and keratinocyte carcinomas in the NIH All of Us Research Program.Archives of dermatological research · 2024Article
- Clinicopathologic comparison of basal cell carcinoma among a diverse patient population in Los Angeles County.Skin health and disease · 2024Article
- Rural-Urban Differences in Sun Exposure and Protection Behaviors in the United States.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024Article
- Do Women with Skin of Color Think They Are Well Represented in Skin Aging Prevention Information?The Journal of clinical and aesthetic dermatology · 2024Article
- Nanotechnology as a Promising Method in the Treatment of Skin Cancer.International journal of molecular sciences · 2024Review
- Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019.Archives of dermatological research · 2023Review
- Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma.Journal of managed care & specialty pharmacy · 2023Article
- Deep convolutional neural network with fusion strategy for skin cancer recognition: model development and validation.Scientific reports · 2023Article
- Skin of colour: essentials for the non-dermatologist.Clinical medicine (London, England) · 2023Review
- Hyperpigmented nodule on a young Black man.JAAD case reports · 2022Article
- Piloting a Community Education Skin Cancer Program Coordinated by Medical Students.JMIR dermatology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople of African, Asian, Hispanic or Latino, Pacific Islander, and Native Indian descent are considered people of color by the Skin of Color Society (SOCS).
objectivesIn this study, we assess incidence, risk factors, clinical characteristics, histopathology, treatment, and survival for skin malignancies in people of color as defined by the SOCS, by systematically reviewing the literature.
methodsAn electronic literature search of the PubMed, EMBASE, and MEDLINE databases was performed. Articles published from 1 January 1990 through 12 December 2020 were included in the search.
resultsWe identified 2666 publications potentially meeting the study criteria. Titles and abstracts of these studies were reviewed and 2353 were excluded. The full text of 313 articles were evaluated and 251 were included in this review.
conclusionDifferences in incidence, patterns, treatment, and survival exist among people of color for cutaneous malignancies. Further research and initiatives are needed to account for and mitigate these differences.
Indexed as
Identifiers
34902111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.